JPMDL Won’t Expedite Hearing On Viagra Skin Cancer MDL Motion

(January 4, 2016, 11:32 AM EST) -- WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) on Dec. 29 denied a joint request by Pfizer Inc. and Viagra plaintiffs to place a motion for a skin cancer multidistrict litigation on the panel’s Jan. 28 agenda (In Re: Viagra Products Liability Litigation, MDL Docket No. 2691, JPMDL)....

Related Sections